Gilead Sciences, Inc.
Gilead Sciences, Inc. (XETRA: GIS) is trading at €151.10, about ₹15,881 at today's EUR/INR rate, as of 10 Nov 2026, 11:35 AM ET, down 0.03% today. Indian residents can buy Gilead Sciences from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
€149.30
Today's high
€153.48
52 week low
€99.98
52 week high
€157.02
GIS opened at €149.38, closed previously at €151.14, and has traded between €99.98 and €157.02 over the past 52 weeks.
About
Gilead Sciences, Inc. is a biopharmaceutical innovator dedicated to the research, development, and global commercialization of medicines that address significant unmet medical needs across the United States, Europe, and other international regions. Its extensive product lineup includes leading treatments for HIV/AIDS, such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla. For COVID-19, the company provides Veklury, an injectable therapy for intravenous administration. Gilead also offers a robust portfolio of drugs combating various liver diseases, specifically Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, it supplies therapeutic solutions for patients with hematological, oncological, and cell-based conditions, including Yescarta, Tecartus, Trodelvy, and Zydelig. Beyond these, its offerings extend to Letairis, an oral medication for pulmonary arterial hypertension; Ranexa, another oral formulation for chronic angina; and AmBisome, a liposomal agent designed to treat serious invasive fungal infections. Incorporated in 1987 and headquartered in Foster City, California, Gilead Sciences actively engages in collaboration agreements with various entities, such as Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc.
Key statistics
Avg. volume
1.04K
Market cap
€187.42B
P/E Ratio
-55.12
Price-to-sales ratio
6.84
Enterprise value
$173.78B
Free cash flow yield
6.09%
Debt-to-equity ratio
2.01
Return on equity
37.62%
ROIC
20.48%
Beta
0.28
Dividend yield
1.90%
Last dividend
€2.85
Financial overview
Revenue
$29.45B
Earnings per share
$6.84
Free cash flow
$9.46B
Net profit margin
-12.47%
Gross margin
79.93%
EBITDA
$13.58B
Revenue growth
2.40%
Similar securities
This is not an investment recommendation
How to buy Gilead Sciences from India
Indian residents can buy Gilead Sciences shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers. Read the full guide: how to invest in Gilead Sciences from India
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.
Search for Gilead Sciences and place an order
Find Gilead Sciences by name or by its ticker, GIS, and choose an order type. Gilead Sciences trades 1:30 pm – 10:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Gilead Sciences position in EUR and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Trading and taxes when buying Gilead Sciences from India
Trading and limits
- Trading hours
- 9:00 am – 5:30 pm CET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Gilead Sciences’ current yield is 1.90%.Dividend tax explained
FAQs
Can Indian residents buy Gilead Sciences stock?
Yes. Gilead Sciences (GIS) has been listed on XETRA since 2000, in the Drug Manufacturers - General industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Gilead Sciences share cost in rupees?
One Gilead Sciences share is €151.10 — about ₹15,881 at an EUR/INR rate of 105.10 on 10 Nov 2026. Both the Gilead Sciences price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Gilead Sciences from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on Gilead Sciences shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the Gilead Sciences price. Paasa issues a capital-gains statement for your return.
Does Gilead Sciences pay a dividend, and how is it taxed in India?
Yes. Gilead Sciences pays a dividend and the current yield is 1.90%; the last declared dividend was €2.85 per share, about ₹299.02. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Gilead Sciences from India?
XETRA trades 1:30 pm – 10:00 pm IST in Indian time. The window shifts to 12:30 pm – 9:00 pm IST when Germany is on daylight time. Orders can only execute during that window.
Is Gilead Sciences a Germany company, and does that change how it is taxed?
Gilead Sciences trades on XETRA in EUR, but the company is domiciled in United States. Gilead Sciences trades as an ordinary share listed directly in Germany, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Gilead Sciences shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Gilead Sciences holding, its cost and its closing value.
How do I sell Gilead Sciences and bring the money back to India?
You sell during market hours (1:30 pm – 10:00 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on Gilead Sciences?
Yes. Gilead Sciences is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.